Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
19MB |
![]() |
Other (Supplementary Information)
15MB |
Item Type: | Article |
---|---|
Title: | ImmuneLENS characterizes systemic immune dysregulation in aging and cancer |
Creators Name: | Bentham, R., Jones, T.P., Black, J.R.M., Martinez-Ruiz, C., Dietzen, M., Litovchenko, M., Thol, K., Watkins, T.B.K., Bailey, C., Pich, O., Zhang, Z., Van Loo, P., Swanton, C. and McGranahan, N. |
Abstract: | Recognition and elimination of pathogens and cancer cells depend on the adaptive immune system. Thus, accurate quantification of immune subsets is vital for precision medicine. We present immune lymphocyte estimation from nucleotide sequencing (ImmuneLENS), which estimates T cell and B cell fractions, class switching and clonotype diversity from whole-genome sequencing data at depths as low as 5× coverage. By applying ImmuneLENS to the 100,000 Genomes Project, we identify genes enriched with somatic mutations in T cell-rich tumors, significant sex-based differences in circulating T cell fraction and demonstrated that the circulating T cell fraction in patients with cancer is significantly lower than in healthy individuals. Low circulating B cell fraction was linked to increased cancer incidence. Finally, circulating T cell abundance was more prognostic of 5-year cancer survival than infiltrating T cells. |
Source: | Nature Genetics |
ISSN: | 1061-4036 |
Publisher: | Nature Publishing Group |
Date: | 18 February 2025 |
Additional Information: | Tom L. Kaufmann is a member of the TRACERx Consortium. |
Official Publication: | https://doi.org/10.1038/s41588-025-02086-5 |
PubMed: | View item in PubMed |
Repository Staff Only: item control page